P

Inventor

MUDRYK BOGUSLAW M

US14 patents

Patents

14 patents
US7396932B2Jul 8, 2008

Process for preparing 4,5-dihydro-pyrazolo[3,4-c]pyrid-2-ones

BRISTOL MYERS SQUIBB CO24 citations90
US8889869B2Nov 18, 2014

Methods for the preparation of HIV attachment inhibitor piperazine prodrug compound

BRISTOL MYERS SQUIBB CO5 citations82
US7629351B2Dec 8, 2009

N-((1R,2S,5R)-5-(tert-butylamino)-2-((S)-2-oxo-3-(6-(trifluoromethyl)quinazolin-4-ylamino) pyrrolidin-1-yl)cyclohexyl)acetamide and other modulators of chemokine receptor activity, crystalline forms and process

BRISTOL MYERS SQUIBB CO5 citations73
US9249168B2Feb 2, 2016

Methods for the preparation of HIV attachment inhibitor piperazine prodrug compound

BRISTOL MYERS SQUIBB CO3 citations71
US9255113B2Feb 9, 2016

Methods for the Preparation of HIV attachment inhibitor piperazine prodrug compound

BRISTOL MYERS SQUIBB CO1 citations61
US9243010B2Jan 26, 2016

Methods for the preparation of HIV attachment inhibitor piperazine prodrug compound

BRISTOL MYERS SQUIBB CO1 citations61
US7304157B2Dec 4, 2007

Efficient synthesis of 4,5-dihydro-pyrazolo[3,4-c]pyrid-2-ones

BRISTOL MYERS SQUIBB CO3 citations60
US8049019B2Nov 1, 2011

Substituted pyrrolidine-2-one compounds

BRISTOL MYERS SQUIBB CO0 citations51
US9403821B2Aug 2, 2016

Methods for the preparation of HIV attachment inhibitor piperazine prodrug compound

BRISTOL MYERS SQUIBB CO0 citations50
US9394322B2Jul 19, 2016

Methods for the preparation of HIV attachment inhibitor piperazine prodrug compound

BRISTOL MYERS SQUIBB CO0 citations50
US9376458B2Jun 28, 2016

Methods for the preparation of HIV attachment inhibitor piperazine prodrug compound

BRISTOL MYERS SQUIBB CO0 citations50
US7579472B2Aug 25, 2009

Efficient synthesis of 4,5-dihydro-pyrazolo[3,4-c]pyrid-2-ones

BRISTOL MYERS SQUIBB CO0 citations49
US7435821B2Oct 14, 2008

Efficient synthesis of 4,5-dihydro-pyrazolo[3,4-c]pyrid-2-ones

BRISTOL MYERS SQUIBB CO0 citations49
US7074921B2Jul 11, 2006

Process for the preparation of 3,7-disubstituted-2,3,4,5-tetrahydro-1H-1,4-benzodiazepine compounds

BRISTOL MYERS SQUIBB CO0 citations39